KRTL BioTech

Early-stage Investing – The Public gets a Seat at the Table

Early-stage Investing – The Public gets a Seat at the Table

FrontFundr | Peter-Paul Van Hoeken | June 12, 2019 Traditionally, only a small group of investors, angel investors and other venture capitalists, have had access to investment opportunities in startups and growth companies. The public has been locked out from investing in startups. Investments in early-stage companies are typically high-risk. That is why early-stage investors